Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets. - Wikidata - wikimedia - TriplyDB

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

http://www.wikidata.org/entity/Q37339933

about

The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials

P2860

Q28087336-553F973C-3AB6-4332-9118-750747D1DD4B

P2860

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

http://www.wikidata.org/entity/Q37339933

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@en

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@nl

type

label

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@en

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@nl

prefLabel

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@en

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@nl

P1433

Q37339933-F0543B8F-C577-44E0-8890-6C5A214327DD

P1476

Q37339933-64810F24-8672-48D0-BCF3-18AF36FC2087

P2093

Q37339933-3EED4250-A62F-45A4-873F-C4C6F3D6C261

Q37339933-C76C92D2-9481-444F-978C-3A2B100FB670

Q37339933-C83B5760-9A68-4753-A538-BC249DE6658A

Q37339933-F9D2FDD1-97E3-45B3-B2E2-12C585909D6A

P2860

Q37339933-089CE336-58E0-4FC6-8A99-A0830018805F

Q37339933-7B895556-2860-4CEC-9770-41F4A9BB61FE

Q37339933-8D63F529-9293-4C01-BEC9-C00ABFE8F515

Q37339933-BBBA63FF-7634-4AF6-A818-5798DD517BA6

P304

Q37339933-C4BA69A4-8E32-4991-9217-7605DDC3CCE3

P31

Q37339933-4E651600-878B-491E-8F2E-2FBE6FB17940

P356

Q37339933-4B8B5EF6-B56B-4628-B330-2F4E9A3B6CE1

P433

Q37339933-36812129-B29B-4E5C-9AE5-8032130E2D84

P478

Q37339933-DAA34A92-CE45-4EC6-A24B-3B6BE94329D9

P577

Q37339933-C2570F4F-12C4-45DE-AFE5-5C27F858A0CD

P698

Q37339933-F947C311-551E-45C9-A335-265B3C500E79

P932

Q37339933-B47D2EAB-D36A-4754-86FB-EE2C8BF35E24

P356

P1433

Hospital pharmacy

P1476

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets.

@en

P2093

Danial E Baker

http://www.w3.org/2001/XMLSchema#string

Dennis J Cada

http://www.w3.org/2001/XMLSchema#string

Silvia Torres

http://www.w3.org/2001/XMLSchema#string

Terri L Levien

http://www.w3.org/2001/XMLSchema#string

P2860

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV.

Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

P304

48-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/HPJ4801-48

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24421423

http://www.w3.org/2001/XMLSchema#string

P932

3839433

http://www.w3.org/2001/XMLSchema#string